Nelson Jane Musser purchased $30K of PEO (indirect holdings)

Nelson Jane Musser purchased 1,010 indirectly-held shares of ADAMS NATURAL RESOURCES FUND, INC. (PEO) at $29.93 on 2026-10-28.

Original reporting
SEC EDGAR · Nelson Jane Musser
Published Oct 30, 2026, 6:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 6:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$PEO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

Minimal impact expected due to small transaction size and lack of broader market relevance.

02

Market read

Routine insider purchase with negligible effect on market pricing.

03

What to watch

No significant ownership shift; transaction size is trivial relative to fund assets.

Relevance 4/10Novelty 4/10Timing: post-market filing

Background

SEC Form 4 filing discloses a director's purchase of 1,010 shares of ADAMS NATURAL RESOURCES FUND, INC. at $29.93 per share, totaling $30,229.30.

Market effects

none

none

none

Counterpoint

The small insider purchase is unlikely to signal material change in fund strategy.

Key entities

  • Nelson Jane Musser

    Insider who purchased shares.

  • ADAMS NATURAL RESOURCES FUND, INC.

    Closed-end fund reporting the insider transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MDGLMedAI 8/10

BAKER BROS. ADVISORS LP (BAKER FELIX, BAKER JULIAN) purchased $35.0M of MDGL (indirect holdings)

BAKER BROS. ADVISORS LP purchased 91,806 indirectly-held shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at an average of $381.49 ($366.99–$396.61, $35.02M total) across 5 trades over 2026-11-04 to 2026-11-06. Filed jointly with Baker Bros. Advisors (GP) LLC (Director), BAKER FELIX (Director), BAKER JULIAN (Director), 667, L.P. (Director) and Baker Brothers Life Sciences LP (Director).